China releases 15th five-year plan targeting 3.5 trillion RMB pharmaceutical revenue by 2030
Ten government agencies jointly published China's pharmaceutical industry roadmap on September 21, 2026, setting a 20%+ annual growth target for innovative drugs and aiming for Chinese-developed first-in-class drugs to represent more than 25% of global new drug approvals by 2030.
3 MIN READ · 23 SEP
Subscriber Content
Subscribe to read the full analysis
Subscribe to read everything on GATE86
Already a subscriber? Log in
Follow this story
Useful?
Next in Today's signals
INDUSTRY · MOBILITY & EV
CATL and NIO pursue rival strategies to control China's battery-swapping market
4 MIN READ · 3 NOV
Related
INDUSTRY · BIOTECH & HEALTH
Beijing Institute of Brain Science and Brain-Inspired Intelligence launches three national BCI major projects
POLICY · AI & DIGITAL
MOFCOM and MOST propose controls on 40 technologies spanning AI, biopharmaceuticals, and solar
INDUSTRY · BIOTECH & HEALTH
